Earnings History Data for Kintara Therapeutics, Inc. (KTRA) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Kintara Therapeutics, Inc.
Kintara Therapeutics Inc. is a biopharmaceutical company. It is focused on the development of new solid tumor cancer therapies. The company's program includes VAL-083 for GBM and REM-001 for cutaneous metastatic breast cancer, which are in clinical stage. Kintara Therapeutics Inc. is based in San Diego, California.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18-09-2023 | PM | KTRA | Kintara Therapeutics | 7.00 | -1.95 | -0.18 | 0.00 | Kintara Therapeutics Non-GAAP EPS of -$9.27 [9/19/2023 12:34 AM] |
4.06 | 0.38 (10.30%) |
3.75 | 0.07 (1.90%) |
2.70 - 15.50 | 10,624 | 10,000 | 2,173 | ||
| 11-05-2023 | PM | KTRA | Kintara Therapeutics | 6.00 | -1.94 | -0.10 | 0.00 | Kintara Therapeutics GAAP EPS of -$1.94 [5/11/2023 9:06 AM] |
3.19 | -0.22 (-6.45%) |
0.0 | 0.0 (0.00%) |
2.70 - 20.00 | 23,388 | 120,000 | 0 | ||
| 14-02-2023 | AH | KTRA | Kintara Therapeutics | 10.00 | -2.10 | -2.80 | 0.00 | 6.06 | -0.10 (-1.62%) |
0.0 | 0.0 (0.00%) |
3.50 - 42.00 | 5,687 | 10,000 | 0 | |||
|
|
||||||||||||||||||
| 27-09-2022 | PM | KTRA | Kintara Therapeutics | 9.00 | -0.07 | -0.03 | 0.00 | Kintara Therapeutics GAAP EPS of -$0.52 [9/27/2022 8:59 AM] |
0.11 | -0.03 (-19.35%) |
0.14 | 0.0 (2.64%) |
0.10 - 1.10 | 3,038,557 | 920,000 | 27,269 | ||
| 29-09-2021 | PM | KTRA | Kintara Therapeutics, Inc. | 29.00 | -0.13 | -0.15 | 0.00 | 0.8260 | -0.04 (-4.73%) |
0.88 | 0.01 (0.92%) |
0.80 - 3.35 | 3,583,019 | 2,460,000 | 221,825 | |||
| 14-05-2021 | PM | KTRA | Kintara Therapeutics, Inc. | 43.00 | -0.23 | -0.17 | 0.00 | Kintara Therapeutics reports FQ3 results [5/14/2021 8:54 AM] |
1.28 | -0.02 (-1.18%) |
1.29 | -0.01 (-0.77%) |
0.61 - 3.35 | 134,286 | 230,000 | 533 | ||
| 12-02-2021 | PM | KTRA | Kintara Therapeutics, Inc. | 68.00 | -0.22 | -0.18 | 0.00 | Kintara Therapeutics reports Q4 results [2/12/2021 8:38 AM] |
2.47 | -0.11 (-4.28%) |
2.48 | -0.10 (-3.87%) |
0.38 - 3.35 | 1,036,502 | 3,307,365 | 35,374 | ||
| 12-02-2021 | PM | KTRA | Kintara Therapeutics, Inc. | 51.79 | -0.22 | -0.17 | -0.15 | Kintara Therapeutics reports Q4 results [2/12/2021 8:38 AM] |
2.58 | -0.16 (-5.84%) |
2.46 | -0.12 (-4.65%) |
0.38 - 3.35 | 1,780,295 | 3,307,365 | 15,319 | ||
| 13-11-2020 | PM | KTRA | Kintara Therapeutics, Inc. | 32.00 | -0.39 | -0.03 | 0.00 | Kintara Therapeutics reports Q1 results [11/13/2020 8:33 AM] |
1.52 | 0.12 (8.19%) |
1.39 | -0.01 (-1.06%) |
0.38 - 1.95 | 608,497 | 143,335 | 4,981 | ||
|
|
||||||||||||||||||